Top Ten Suppliers Shaping the Global Synthetic Biology Market

Top Ten Suppliers Shaping the Global Synthetic Biology Market


Apr 19, 2024

Blog Biotechnology Top Ten Suppliers Shaping the Global Synthetic Biology Market

Synthetic biology is a multidisciplinary field of science that combines engineering principles with biology to create new biological systems or to redesign existing natural systems. It involves creating artificial biological systems for practical uses in energy, medicine, and the environment. The main aim is to design biological systems for specific tasks, using genetic engineering to enhance existing organisms or create new ones with specialized functions. For example, integrating spider DNA into silkworms can result in super strong, ultra-lightweight silk production.

According to BCC Research, the global synthetic biology market is poised to experience substantial growth, with the market size expected to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028. This growth is driven by a compound annual growth rate (CAGR) of 10.8% during the forecast period of 2023-2028. Today we’ll explore the top ten suppliers that are driving this transformative industry forward.



Top Ten Suppliers of Synthetic Biology Technology

The global market for synthetic biology is expected to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 10.8% during the forecast period of 2023-2028.

Top 10 Synthetic Biology Industry Leaders by Revenue

Agilent Technologies Inc. (Revenue 2022: $6,848.0 Million)

Established in 1999 as a spin-off from Hewlett-Packard, Agilent Technologies Inc. is a global leader in providing instruments, software, services, and consumables for various applications in chemical analysis, life sciences, and diagnostics. Their products include DNA synthesis tools, genome editing technologies, and analytical instruments for genomics and proteomics research.

Agilent Technologies (AATI) has made 33 acquisitions across various sectors, including life sciences and enterprise technology.

Amyris, Inc. (Revenue 2022: $269.8 Million)

Established in 2003, Amyris is a US-based synthetic biotechnology company specializing in sustainable ingredient manufacturing. Using sugarcane fermentation, it converts plant sugars into bioidentical molecules for various products, including anti-wrinkle skincare, zero-calorie sweeteners, life-saving medications, fine fragrances, and polymers for electronic circuits.

Amyris has made eight acquisitions across sectors such as Beauty Tech, Consumer Digital - US, Beauty E-Commerce, and others.

Codexis (Revenue 2022: $138.6 Million)

Founded in 2002, Codexis is a biotechnology company that discovers, develops, and markets enzymes and other proteins for a variety of industries, including pharmaceuticals, fine chemicals, biotherapeutics, food and beverage, and agriculture. The company's Code Evolver platform in synthetic biology creates gene variant libraries that encode biocatalysts with new functions.

GenScript (Revenue 2022: $625.7 Million)

Founded in 2002, GenScript is a US based global biotechnology company that provides a wide range of products and services for life science research & development. The company's synthetic biology products and services include gene synthesis, DNA sequencing, and protein engineering. GenScript also offers a variety of custom synthetic biology services, such as the design and construction of synthetic genes and pathways. GenScript Biotech operates in China, Singapore, Japan, the United Kingdom, the Netherlands, and several other countries.

Gilead Sciences, Inc. (Revenue 2022: $27,281 Million)

Established in 1987, Gilead Sciences is an American biopharmaceutical company specializing in antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. Operating in over 35 countries, Gilead's commitment to innovation in the field of synthetic biology makes it a valuable partner for companies that are developing new drugs and therapies.

As of January 2024, Gilead Sciences has made 17 acquisitions across sectors such as biopharmaceuticals, life sciences, and oncology.

Ginkgo Bioworks (Revenue 2022: $477.7 Million)

Established in 2008 as a spinout from the Massachusetts Institute of Technology, Ginkgo Bioworks is a synthetic biology company that designs and engineers organisms for various applications. Ginkgo Bioworks is a key player in the global synthetic biology market, known as one of the largest suppliers of synthetic DNA worldwide. Partnering with leading pharmaceutical and biotechnology companies, they lead in developing innovative synthetic biology technologies like the Foundry platform, which allows scientists to design and engineer organisms in a high-throughput manner.

Novozymes (Revenue 2022: $2,518 Million)

Founded in 2000, Novozymes is a Denmark-based global biotechnology company, the world's largest producer of industrial enzymes, with an estimated global market share of 47%. Their products include Industrial enzymes, Microorganisms, Biopharmaceutical ingredients, and Consumer health solutions. used across industries such as food and beverage, bioenergy, agriculture, and pharmaceuticals.

As of January 2024, Novozymes has made 14 acquisitions across sectors like AgriTech, B2B AgriTech, and Life Sciences - Europe, spending over $1.1 billion on acquisitions.

Thermo Fisher Scientific (Revenue 2022: $ 44,915 Million)

Thermo Fisher Scientific, formed in 2006 through the merger of Thermo Electron and Fisher Scientific, is an American supplier of life sciences solutions, analytical instruments, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services. Their synthetic biology offerings include gene editing tools, synthetic DNA, and cell engineering technologies.

Thermo Fisher Scientific has made 52 acquisitions across various sectors and has spent over $94 billion for acquisitions.

Twist Bioscience (Revenue 2022: $203.6 Million)

Founded in 2013, Twist Bioscience specializes in synthetic DNA and gene synthesis, offering high-quality, custom-designed DNA constructs to researchers worldwide. They offer a wide range of synthetic DNA products, including genes, libraries, and tools for next-generation sequencing (NGS) preparation. Twist Bioscience's advanced DNA synthesis platform enables rapid and cost-effective production of synthetic DNA.

The company has made three acquisitions across sectors such as Deep Tech, Enterprise Tech - US, and Life Sciences – US, with their most recent acquisition being Abveris in November 2021 for $190 million.

Verbio SE (Revenue 2022: $1882.7 Million)

Established in 2006, Verbio SE is a German company specializing in producing biofuels and chemical products from renewable resources like rapeseed oil, rye, wheat, triticale, maize, and straw. It is a leading producer of biodiesel and bioethanol in Europe, also producing biofertilizers, biogas, and other renewable products.

Verbio SE acquired South Bend Ethanol in 2023 from Mercuria Investments U.S. Inc. for $230 million.

In conclusion, the global synthetic biology market is fueled by the innovative solutions and technologies offered by leading suppliers. From custom DNA synthesis to genome editing technologies, these companies are driving advancements in synthetic biology, paving the way for transformative applications in various industries. As the field continues to evolve, collaboration and innovation among these top suppliers will play a crucial role in shaping the future of biotechnology.

Learn More and Take Action:

Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.

Contact us today to find out more.

    Stay ahead of industry trends, build your market research strategy and more.

    Karishma Arora

    Written By Karishma Arora

    Karishma Arora is an Assistant Team Lead in Marketing Operations at BCC Research, with a master's degree in commerce. She is a passionate marketer with a knack for creativity and data-driven strategies.

    Guiding smart decisions every step of the way

    Guiding smart decisions every step of the way

    We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond.

    Contact Us